AMANDA ALBERTSEN: Open Payments
NPI 1386964641 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, INGREZZA, INVEGA SUSTENNA, VRAYLAR, COBENFY.
Industry payments across TN — which companies pay providers there.
